Literature DB >> 25774062

Effectiveness of total contact insoles in patients with plantar fasciitis.

Hilda Alcântara Veiga Oliveira1, Anamaria Jones1, Emília Moreira1, Fabio Jennings1, Jamil Natour2.   

Abstract

OBJECTIVE: To assess the effectiveness of total contact insoles (TCI) in patients with plantar fasciitis (PF).
METHODS: A double-blind randomized controlled trial was carried out with intention-to-treat analysis. Seventy-four patients were randomly allocated to use a TCI made of ethylene vinyl acetate (study group, n = 37) or a flat insole (control group, n = 37). The following assessment tools were used: visual analog scale for pain while walking and at rest, Medical Outcomes Study Short Form-36 (SF-36) for quality of life, Foot Function Index and Foot Health Status Questionnaire for foot function, 6-min walk test (6MWT), and baropodometer FootWalk Pro for plantar pressure analysis. The groups were evaluated by a blinded assessor at baseline and after 45, 90, and 180 days.
RESULTS: The groups were homogeneous for the majority of variables at baseline. The over-time comparisons show a statistical difference between the groups for pain while walking (p = 0.008) and the 6MWT (p = 0.010). Both groups showed significant improvements in pain at rest, foot function, and some quality of life variables (physical functioning, bodily pain, vitality, and social functioning), with no significant statistical differences between them. The baropodometer recorded no changes from the use of the insoles.
CONCLUSION: A TCI can be used to reduce pain while walking and to increase walking distance in individuals with PF.

Entities:  

Keywords:  FOOT; GAIT; ORTHOPEDIC DEVICES; PAIN; PLANTAR FASCIITIS

Mesh:

Year:  2015        PMID: 25774062     DOI: 10.3899/jrheum.140429

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Relationship between patient-reported outcome measures (PROM) and three measures of foot-ankle alignment in patients with metatarsal head pain: a cross-sectional study.

Authors:  Manuel González-Sánchez; Esther Velasco-Ramos; Maria Ruiz Muñoz; Antonio I Cuesta-Vargas
Journal:  J Foot Ankle Res       Date:  2016-12-16       Impact factor: 2.303

2.  Biomechanical Parameters in Plantar Fasciitis Measured by Gait Analysis System With Pressure Sensor.

Authors:  Seung Don Yoo; Hee Sang Kim; Jong Ha Lee; Dong Hwan Yun; Dong Hwan Kim; Jinmann Chon; Seung Ah Lee; Yoo Jin Han; Yun Soo Soh; Yong Kim; Seonyoung Han; Woojin Lee; Young Rok Han
Journal:  Ann Rehabil Med       Date:  2017-12-28

Review 3.  A systematic review of randomised controlled trials assessing effectiveness of prosthetic and orthotic interventions.

Authors:  Aoife Healy; Sybil Farmer; Anand Pandyan; Nachiappan Chockalingam
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

4.  Comparative efficacy of corticosteroid injection and non-invasive treatments for plantar fasciitis: a systematic review and meta-analysis.

Authors:  Chien-Min Chen; Meng Lee; Chia-Hung Lin; Chia-Hao Chang; Chu-Hsu Lin
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

5.  Influences of methotrexate iontophoresis on functional lifestyle disabilities, functional capacity, and pain in patients with plantar psoriasis.

Authors:  Nermeen Mohamed Abdelhalim; Ahmed Fathy Samhan
Journal:  Turk J Phys Med Rehabil       Date:  2022-06-01

6.  Corticosteroid injections compared to foot orthoses for plantar heel pain: protocol for the SOOTHE heel pain randomised trial.

Authors:  Glen A Whittaker; Shannon E Munteanu; Hylton B Menz; Ayman Elzarka; Karl B Landorf
Journal:  Contemp Clin Trials Commun       Date:  2016-11-23

Review 7.  Management of plantar heel pain: a best practice guide informed by a systematic review, expert clinical reasoning and patient values.

Authors:  Dylan Morrissey; Matthew Cotchett; Ahmed Said J'Bari; Trevor Prior; Ian B Griffiths; Michael Skovdal Rathleff; Halime Gulle; Bill Vicenzino; Christian J Barton
Journal:  Br J Sports Med       Date:  2021-03-30       Impact factor: 13.800

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.